Shamseddin Ahmadi

Dr. Shamseddin Ahmadi


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2011 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
PDF file
MBMaryam Bananej
Maryam Bananej
AKAhmad Karimi-Sori
Ahmad Karimi-Sori
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast
SAShamseddin Ahmadi
Shamseddin Ahmadi
Involvement of the dopamine receptors in the basolateral amygdala (BLA) in the effects of histamine on anxiety-like behaviors of the elevated plus maze in male Wistar rats was investigated. The results showed that bilateral intra-BLA injections of histamine (2.5, 5 and 7.5 µg/rat) induced an anxiogenic-like effect, revealed by decreases in percentage of open arm time (%OAT) and open arm entries (%OAE). Intra-BLA administration of dopamine D1 receptor agonist, SKF38393 (0.25 µg/rat), and dopamine D2 receptor agonist, quinpirole (0.03 and 0.05 µg/rat), decreased %OAT but not %OAE. Conversely, intra-BLA administration of dopamine D1 receptor antagonist, SCH23390 (0.5 and 1 µg/rat), and dopamine D2 receptor antagonist, sulpiride (0.3 and 0.5 µg/rat), increased %OAT and %OAE, suggesting an anxiolytic-like effect for both drugs. Interestingly, co-administration of a silent dose of SCH23390 or sulpiride prevented anxiogenic-like effects of SKF38393 and quinpirole, respectively. Conjoint administration of a sub-effective dose of SKF38393 (0.125 µg/rat) or quinpirole (0.01 µg/rat) along with lower doses of histamine (1 and 2.5 µg/rat) induced anxiolytic-like effects. On the other hand, intra-BLA pretreatment with a silent dose of SCH23390 (0.25 µg/rat) or sulpiride (0.1 µg/rat) prevented the anxiogenic-like effect of higher doses of histamine (5 and 7.5 µg/rat). No significant change was observed in total closed arm entries, as an index for motor activity of the animals. It can be concluded that the dopamine D1 and D2 receptors in the BLA may be involved in the anxiogenic-like effects induced by histamine.

1 April 2004 in Brain Research
Verified
Journal Article
Closed access
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast
SAShamseddin Ahmadi
Shamseddin Ahmadi
AHAli Haeri-Rohani
Ali Haeri-Rohani
ARAmeneh Rezayof
Ameneh Rezayof
MJMohammad-Reza Jafari
Mohammad-Reza Jafari
MJMajid Jafari-Sabet
Majid Jafari-Sabet

17 March 2020 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
SAShamseddin Ahmadi
Shamseddin Ahmadi
MZMohammad Zobeiri
Mohammad Zobeiri
SBSteven Bradburn
Steven Bradburn

20 March 2007 in Developmental Neurobiology
Verified
Journal Article
Closed access
PDF file
SAShamseddin Ahmadi
Shamseddin Ahmadi
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast
AHAli Haeri‐Rohani
Ali Haeri‐Rohani
ARAmeneh Rezayof
Ameneh Rezayof
MNMaryam Nouri
Maryam Nouri

1 April 2012 in Behavioural Brain Research
Verified
Journal Article
Closed access
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast
AAAbolfazl Ardjmand
Abolfazl Ardjmand
SAShamseddin Ahmadi
Shamseddin Ahmadi
ARAmeneh Rezayof
Ameneh Rezayof

4 August 2010 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
PDF file
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast
SMSara Mahboobi
Sara Mahboobi
MSMitra-Sadat Sadat-Shirazi
Mitra-Sadat Sadat-Shirazi
SAShamseddin Ahmadi
Shamseddin Ahmadi
In the present study the influence of the dopaminergic system(s) of the amygdala on the anxiolytic-like effect of the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in male Wistar rats was investigated. An elevated plus-maze test of anxiety was used to assess anxiety-like behaviors. The results showed that bilateral intra-amygdala injections of ACPA (0.125, 1.25 and 5 ng/rat) and the mixed dopamine D1/D2 receptor agonist, apomorphine, at different doses (0.001, 0.01 and 0.1 µg/rat) increased percentage open arm time (%OAT) and percentage open arm entries (%OAE), indicating an anxiolytic-like effect for both of the drugs. In contrast, intra-amygdala administration of the dopamine D1 receptor antagonist SCH23390 (0.5 and 1 µg/rat) and the dopamine D2 receptor antagonist, sulpiride (2 and 3 µg/rat) decreased %OAT and %OAE, suggesting an anxiogenic-like effect for both of the drugs. Interestingly, pretreatment with a sub-effective dose of apomorphine (0.0005 µg/rat) increased, while SCH23390 (0.25 µg/rat) and sulpiride (1.5 µg/rat) decreased the anxiolytic-like effect of ACPA. It can be concluded that the dopaminergic system of the amygdala may be involved, at least partly, in the anxiolytic-like effects induced by ACPA in the rat amygdala.